![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/twitter.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/Logo_LinkedIn_round.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/youtube.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/flickr.png)
The off-patent medicines sector accounts for almost 70% of medicines dispensed in Europe, helping to manage the most prevalent chronic diseases including cancer, auto-immune conditions, cardiac disease, and diabetes. Value added medicines promise affordable, patient-centred innovation which can address serious health needs.